Jason Cameron

1.4k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Jason Cameron is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics. According to data from OpenAlex, Jason Cameron has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Jason Cameron's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Protein purification and stability (6 papers). Jason Cameron is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Protein purification and stability (6 papers). Jason Cameron collaborates with scholars based in Denmark, Norway and United Kingdom. Jason Cameron's co-authors include Leslie Evans, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Kenneth A. Howard, Andrew Plumridge, Bjørn Dalhus, Kristin Støen Gunnarsen, Magnar Bjørås and Dorthe Viuff and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Controlled Release.

In The Last Decade

Jason Cameron

17 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Albumin as a versatile platform for drug half-life extension

2013 376 citations Darrell Sleep, Jason Cameron et al. Biochimica et Biophysica Acta (BBA) - General Subjects profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason Cameron Denmark	16	747	571	188	159	135	18	1.1k
Jeannette Nilsen Norway	12	447 0.6×	350 0.6×	122 0.6×	116 0.7×	130 1.0×	18	819
Malin Bern Norway	10	458 0.6×	377 0.7×	101 0.5×	89 0.6×	166 1.2×	12	776
Marianne Budde Netherlands	12	553 0.7×	716 1.3×	359 1.9×	84 0.5×	156 1.2×	14	1.4k
Shauna West United Kingdom	15	526 0.7×	289 0.5×	102 0.5×	57 0.4×	168 1.2×	20	849
Michael Lykke Hvam Denmark	10	968 1.3×	141 0.2×	123 0.7×	194 1.2×	110 0.8×	12	1.3k
Xiaoyang Zheng United States	11	472 0.6×	220 0.4×	151 0.8×	55 0.3×	72 0.5×	15	863
Mariana Varna France	21	589 0.8×	150 0.3×	566 3.0×	187 1.2×	116 0.9×	40	1.5k
Green Ahn United States	11	1.3k 1.8×	171 0.3×	518 2.8×	54 0.3×	224 1.7×	11	1.6k
Lihua Huang United States	18	1.0k 1.3×	520 0.9×	75 0.4×	32 0.2×	311 2.3×	42	1.4k
Suzanne Hermeling Netherlands	8	783 1.0×	567 1.0×	86 0.5×	55 0.3×	335 2.5×	8	1.1k

Countries citing papers authored by Jason Cameron

Since Specialization

Citations

This map shows the geographic impact of Jason Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Cameron more than expected).

Fields of papers citing papers by Jason Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Cameron. The network helps show where Jason Cameron may publish in the future.

Co-authorship network of co-authors of Jason Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Cameron. A scholar is included among the top collaborators of Jason Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Cameron. Jason Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tan, Shuai, et al.. (2025). Aggregate Suppression of Recombinant Human Serum Albumin (HSA) by Adenosine Triphosphate (ATP). Molecular Pharmaceutics. 22(10). 6258–6269.

Bernardim, Barbara, João Conde, Tuuli A. Hakala, et al.. (2024). Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates. Bioconjugate Chemistry. 35(2). 132–139. 3 indexed citations

Larsen, Maja Thim, Yonglun Luo, Karina D. Sørensen, et al.. (2020). FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs. Journal of Controlled Release. 322. 53–63. 35 indexed citations

Dagnæs‐Hansen, Frederik, Karen Bunting, Helen Rawsthorne, et al.. (2019). A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation. Journal of Biological Chemistry. 294(10). 3735–3743. 15 indexed citations

Larsen, Maja Thim, et al.. (2018). Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement. Journal of Controlled Release. 287. 132–141. 32 indexed citations

Kuhlmann, Matthias, et al.. (2017). Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding. Nanotechnology. 28(20). 204004–204004. 19 indexed citations

Schmidt, Esben Gjerløff Wedebye, Michael Lykke Hvam, Filipa Antunes, et al.. (2017). Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin. Journal of Biological Chemistry. 292(32). 13312–13322. 68 indexed citations

Caspersen, Mikael B., Matthias Kuhlmann, Malcolm J. Saxton, et al.. (2017). Albumin-based Drug Delivery Using Cysteine 34 Chemical Conjugates–Important Considerations and Requirements. Therapeutic Delivery. 8(7). 511–519. 20 indexed citations

Hvam, Michael Lykke, Malgorzata Maria Pakula, Frederik Dagnæs‐Hansen, et al.. (2016). An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencing. Journal of Controlled Release. 232. 143–151. 32 indexed citations

10.

Viuff, Dorthe, Filipa Antunes, Leslie Evans, et al.. (2015). Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs. Journal of Controlled Release. 223. 22–30. 37 indexed citations

11.

Ebbesen, Morten Frendø, et al.. (2015). Neonatal Fc Receptor Binding Tolerance toward the Covalent Conjugation of Payloads to Cysteine 34 of Human Albumin Variants. Molecular Pharmaceutics. 13(2). 677–682. 20 indexed citations

12.

Sand, Kine Marita Knudsen, Malin Bern, Jeannette Nilsen, et al.. (2014). Interaction with Both Domain I and III of Albumin Is Required for Optimal pH-dependent Binding to the Neonatal Fc Receptor (FcRn). Journal of Biological Chemistry. 289(50). 34583–34594. 42 indexed citations

13.

Sand, Kine Marita Knudsen, Bjørn Dalhus, Gregory J. Christianson, et al.. (2014). Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies. Journal of Biological Chemistry. 289(24). 17228–17239. 37 indexed citations

14.

Andersen, Jan Terje, Bjørn Dalhus, Dorthe Viuff, et al.. (2014). Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding. Journal of Biological Chemistry. 289(19). 13492–13502. 132 indexed citations

15.

Andersen, Jan Terje, Jason Cameron, Andrew Plumridge, et al.. (2013). Single-chain Variable Fragment Albumin Fusions Bind the Neonatal Fc Receptor (FcRn) in a Species-dependent Manner. Journal of Biological Chemistry. 288(33). 24277–24285. 56 indexed citations

16.

Sleep, Darrell, Jason Cameron, & Leslie Evans. (2013). Albumin as a versatile platform for drug half-life extension. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(12). 5526–5534. 376 indexed citations breakdown →

17.

Andersen, Jan Terje, Bjørn Dalhus, Jason Cameron, et al.. (2012). Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nature Communications. 3(1). 610–610. 161 indexed citations

18.

Evans, Leslie, et al.. (2010). The production, characterisation and enhanced pharmacokinetics of scFv–albumin fusions expressed in Saccharomyces cerevisiae. Protein Expression and Purification. 73(2). 113–124. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact